PROVIDER PROFILE · NPI 1740202266
James VapM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
3,326
Unique beneficiaries
—
Total services
11,050
Distinct HCPCS
19
Medicare payment
$301K
Peer benchmark
Total Medicare services vs. 37 Otolaryngology providers in DC — top quintile (cohort median 641).
PRESCRIBING · PART D · 2024
Total Rx claims
687
Beneficiaries
—
Total drug cost
$26K
Distinct drugs
21
Brand share
43.4%
Top prescribed drugs
Amoxicillin/Potassium Clav101 claims
Doxycycline Hyclate100 claims
Triamterene/Hydrochlorothiazid85 claims
Prednisone65 claims
Ciprofloxacin Hcl/Dexameth42 claims
QUALITY · MIPS · 2024
Final MIPS score
0.0
Quality
0.0
Cost
0.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
-9.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
REFERRAL NETWORK
Where James Vap's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 10 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Quest Diagnostics Incorporated Md Clinical Laboratory · Baltimore, MD | 275 | 1,168 |
| Patrick Maiberger Otolaryngology · Martinsburg, WV | 52 | 259 |
| LUCY WEBB HAYES NATIONAL TRAINING SCHOOL FOR DEACONESSES & MISSIONARIE | 43 | 139 |
| BETHESDA DERMATOPATHOLOGY LAB INC. | 22 | 48 |
| Sunrise Medical Laboratories, Inc. Clinical Laboratory · Hicksville, NY | 21 | 63 |
| MEDSTAR - GEORGETOWN MEDICAL CENTER, INC. | 20 | 63 |
| Quest Diagnostics Nichols Institute, Inc. Clinical Laboratory · Chantilly, VA | 20 | 67 |
| Mid-Atlantic Pathology Services, Inc. Clinical Laboratory · Sterling, VA | 18 | 44 |
| NPI 1457306805 | 12 | 23 |
| SOLSTAS LAB PARTNERS GROUP LLC | 12 | 67 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE